We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$32.9B
AUM Growth
-$855M
Cap. Flow
-$1.55B
Cap. Flow %
-4.7%
Top 10 Hldgs %
29.62%
Holding
1,163
New
73
Increased
397
Reduced
461
Closed
98

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$87.5M
2
SHW icon
Sherwin-Williams
SHW
+$76.1M
3
HD icon
Home Depot
HD
+$68M
4
LIN icon
Linde
LIN
+$55M
5
BMY icon
Bristol-Myers Squibb
BMY
+$50.3M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$95.3M
2
AAPL icon
Apple
AAPL
+$83.2M
3
AVGO icon
Broadcom
AVGO
+$76.2M
4
ELV icon
Elevance Health
ELV
+$71.4M
5
NVDA icon
NVIDIA
NVDA
+$69.2M

Sector Composition

Rank Sector Weight
1 Technology 37.44%
2 Healthcare 14.27%
3 Consumer Discretionary 12.23%
4 Financials 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$322B
$130M 0.4%
1,310,947
+76,424
+6% +$7.88M
ABT icon
52
Abbott
ABT
$188B
$125M 0.38%
1,109,534
-312,735
-22% -$36.1M
CME icon
53
CME Group
CME
$95.4B
$122M 0.37%
525,353
-50,309
-9% -$11.6M
AXON
54
Axon Enterprise
AXON
$42.8B
$118M 0.36%
198,910
-54,531
-22% -$29.7M
GMED icon
55
Globus Medical
GMED
$11.1B
$118M 0.36%
1,423,195
-37,013
-3% -$2.92M
BMY icon
56
Bristol-Myers Squibb
BMY
$129B
$115M 0.35%
2,032,194
+900,240
+80% +$50.3M
AMAT icon
57
Applied Materials
AMAT
$347B
$113M 0.34%
695,316
-287,167
-29% -$52M
ZBRA icon
58
Zebra Technologies
ZBRA
$13.5B
$113M 0.34%
292,486
+4,120
+1% +$1.6M
NFLX icon
59
Netflix
NFLX
$307B
$113M 0.34%
1,266,050
-111,900
-8% -$9.21M
JNJ icon
60
Johnson & Johnson
JNJ
$640B
$111M 0.34%
765,551
+73,756
+11% +$11.4M
NXPI icon
61
NXP Semiconductors
NXPI
$60.8B
$110M 0.34%
530,993
-99,235
-16% -$22.6M
ECL icon
62
Ecolab
ECL
$79.8B
$110M 0.33%
468,718
-16,027
-3% -$3.98M
BDX icon
63
Becton Dickinson
BDX
$46.4B
$107M 0.32%
471,120
+19,734
+4% +$4.56M
RSG icon
64
Republic Services
RSG
$67.4B
$106M 0.32%
526,270
+4,792
+0.9% +$992K
WDAY icon
65
Workday
WDAY
$41.5B
$105M 0.32%
405,888
-95,951
-19% -$24.5M
STLA icon
66
Stellantis
STLA
$17.4B
$99.8M 0.3%
7,894,036
-1,261,729
-14% -$16.7M
UNP icon
67
Union Pacific
UNP
$174B
$98.6M 0.3%
432,599
-112,726
-21% -$26.7M
TER icon
68
Teradyne
TER
$50B
$97.9M 0.3%
777,113
+87,457
+13% +$10.3M
GE icon
69
GE Aerospace
GE
$364B
$97.6M 0.3%
585,234
+1,810
+0.3% +$323K
BLK icon
70
Blackrock
BLK
$167B
$95.6M 0.29%
93,275
+789
+0.9% +$801K
ROP icon
71
Roper Technologies
ROP
$40.4B
$94.9M 0.29%
182,515
+8,903
+5% +$4.89M
TXN icon
72
Texas Instruments
TXN
$248B
$92.1M 0.28%
491,421
+10,277
+2% +$2.05M
TRMB icon
73
Trimble
TRMB
$13.6B
$90.1M 0.27%
1,274,729
-104,635
-8% -$7.11M
FISV
74
Fiserv Inc
FISV
$29.7B
$87.9M 0.27%
427,733
-6,472
-1% -$1.32M
CTSH icon
75
Cognizant
CTSH
$26.5B
$85.6M 0.26%
1,113,396
+13,888
+1% +$1.09M

Similar funds

Axa's Q4 2024 Portfolio in Review

As of Q4 2024, Axa held 1,163 positions worth $32.9B, down 2.5% from $33.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Axa withdrew a net $1.55B in Q4 2024, closing 98 positions and reducing 461 holdings. Its most notable exit was Altair Engineering Inc, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in JBT Marel worth $34.4M.

  • Axa's largest Q4 2024 buy was JBT Marel: 270,829 shares worth $34.4M.
  • Axa added most to Salesforce in Q4 2024, an estimated $87.5M increase.
  • Axa's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $95.3M.
  • Axa fully exited Altair Engineering Inc in Q4 2024, selling an estimated $67.5M.
  • Axa's ten largest holdings make up 30% of its $32.9B portfolio in Q4 2024.
  • Axa opened 73 new positions and closed 98 in Q4 2024.
  • Axa's portfolio value fell 2.5% quarter-over-quarter to $32.9B.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.